The liver fluke Fasciola hepatica infects a wide range of hosts, and has a considerable impact on the agriculture industry, mainly through infections of sheep and cattle. Further, human infection is now considered of public health importance and is hyperendemic in some regions. The fluke infection causes considerable damage to the hosts' liver. However, the mechanisms of liver destruction have not yet been completely elucidated. In the present report we incubated a human liver cell line in the presence of either F. hepatica excretory/secretory material (FhES) or recombinant phosphoglycerate kinase (FhPGK). Dosedependent cytotoxicity in the presence of FhES was observed, indicating that FhES is capable of killing human hepatocytes, supporting a role for FhES in damaging host liver cells during infection; while treatment with a recombinant intracellular protein -FhPGK, had no impact on cell survival.
Fasciola hepatica can infect a wide range of mammalian species including humans. Human fasciolosis is an emerging disease of public health significance and a number of hyperendemic regions have been reported (Mas-Coma 2005) ; estimates of infection range from 2.4 to 17 million worldwide, with a further 180 million at risk of infection (WHO 1995) .
Fasciolosis pathology is mainly associated with liver damage; caused by mechanical damage to tissues in the process of parasite migration, the activity of fluke secreted products, and the inflammation process resulting from activity of the host immune system (reviewed in Behm and Sangster 1999) .
Fasciola hepatica-host molecular interactions have been investigated for several years. While the roles of tegumental antigens (Hamilton et al. 2009 ) and whole fluke homogenates (Flynn et al. 2007) in pathogenicity are also of interest to researchers, most reports have described the effects of F. hepatica excretory/secretory material (FhES), or its purified components, on host immune cells. It is now known that FhES components can induce alternatively activated macrophages (Donnelly et al. 2005; Flynn et al. 2007) , and apoptosis of peritoneal macrophages (Guasconi et al. 2012) and eosinophils (Serradell et al. 2009 ). There are only limited data concerning the effects of F. hepatica proteins on hepatocytes; it has been shown that both somatic (Wesołowska et al. 2012) and FhES (Gajewska et al. 2006) fractions influence survival of rat hepatocytes in vitro. In this study we determined the cytotoxic potential of FhES and the strictly intracellular protein -phosphoglycerate kinase (FhPGK) on Hep-G2 cells (a human hepatocyte cell line).
Piotr Bąska et al. 216 Adult flukes were isolated from the livers of experimentally infected rats. To eliminate host tissue residues flukes were incubated in PBS (with buffer changes) at 37°C for 2 h, then in RPMI 1640 medium at 37°C, 5% CO 2 for 2.5 h, with the medium then discarded. Flukes were then incubated in RPMI 1640 medium replaced at 60-80 min intervals, with a total of 7 media changes. Each RPMI 1640 medium fraction containing FhES was stored at -20°C. The obtained FhES was concentrated using an AMICON filter (Millipore) with a 3 kDa cutoff.
In order to clone FhPGK, the primer PolyT (5'CTC-GAGTTTTTTTTTTTTTTTTTTTTTTTTT) and FhpgkL (5'AATCTAGAATGGGTCTGAAAAAGTTGAG; designed based on Genbank database sequence DQ112667) were used for the amplification of the complete coding region of F. hepatica newly excysted juvenile phosphoglycerate kinase cDNA. The resulting PCR product was subsequently cloned into pGEM-T Easy (Promega) and sequenced.
For expression of recombinant FhPGK in E. coli, the primers PGK-E.coli-L-EcoRI (5'ATGAATTCATGGGTCT-GAAAAAGTTG) and PGK-E.coli-R-NotI (5'ATGCGGC-CGC TCAGGCGTTAGTGAGTGC) were used to amplify the coding region. The amplified fragment was cloned into the pGEM-T Easy vector. The construct was then digested with the restriction enzymes EcoRI and NotI, and the fragment encoding FhPGK was ligated with EcoRI and NotI digested pET21a+ vector. The recombinant vector was cloned and its integrity was confirmed by sequencing. The bacteria were grown to OD 600 =0.6 and expression was induced with 1 M IPTG. The culture was incubated for a further 2 h, spun and the bacterial pellet stored at -20°C until used. The pellet was thawed in equilibration buffer (10 mM imidazole, 300 mM NaCl, 50 mM Na 3 PO 4 , pH 8), sonicated, then spun. The supernatant was retained and the pellet was resuspended in equilibration buffer, sonicated and spun. The supernatants were combined, filtered and incubated with Nickel His affinity Gel (Sigma Aldrich) in a 50 ml conical tube on a hematological mixer at 4°C. The gel was then incubated 4 times for 15 min (4°C) in equilibration buffer supplemented with 1% Triton X-114, then rinsed 8 times in equilibration buffer at 4°C. The protein was eluted in the presence of 250 mM imidazole at room temperature, then concentrated and buffer exchanged into PBS using a 3 kDa AMICON filter (Millipore).
Cytotoxicity was determined using the MTS assay, which is an improvement of the widely used MTT assay. Hep-G2 cells (a human liver hepatocellular cell line) were seeded in a 96 deep well dish (1000 cells per well). After 18 h, cells were treated for 72 h with FhES (0 to 630 µg/ml) or FhPGK (0 to 200 µg/ml). The assay was performed in triplicate. Untreated, and doxorubicin stimulated cells were considered negative and positive controls, respectively. Since FhES was solubilized in RPMI 1640 and FhPGK was solubilized in PBS, cells were simultaneously stimulated with RPMI 1640 and PBS.
Incubation of Hep-G2 cells in the presence of FhES derived from adult fluke resulted in cell death. The level of cell death was dose-dependent ( Fig. 1) . Decreasing levels of cell survival were observed in the presence of increasing amounts of FhES up to 136 µg/ml; however, these decreases in cell survival progressively diminished as concentrations of FhES rose above 136 µg/ml. The observed decreasing effect of FhES at the higher concentrations might be caused by overloading of the culture since the concentrations (< 378 µg/ml) seem to be higher than would be physiologically expected. Alternatively, no effect on cell survival was evident with cells treated with FhPGK (Fig. 1) .
In this study, we found that FhES derived from adult fluke caused damage to cells of a human hepatocyte cell line in vitro. Our results are consistent with those achieved by Gajewska et al. (2006) who showed that rat hepatocyte cell death is caused by FhES products. Similar results have also been obtained when rat liver cells were treated with homogenate of adult F. hepatica (Wesołowska et al. 2012) . Several proteomic studies on the composition of F. hepatica ES have been undertaken in recent years, and numerous proteins have been found in adult F. hepatica ES, the most abundant of which appear to be the cathepsin L proteases which have been shown to digest basement membrane and extracellular matrix proteins including collagen, fibronectin and laminin, suggesting Fasciola hepatica ES (A) produced dose-dependent death of Hep-G2 cells, whereas this effect was not observed for cells treated with FhPGK (B) Cytotoxicity of Fasciola hepatica ES 217 roles in migration (Berasain et al. 1997; Norbury et al. 2011 ). FhES has also been shown to contain various antioxidant proteins including fatty acid binding proteins (FABPs), peroxiredoxin, thioredoxin, and glutathione S-transferases (Jefferies et al. 2001; Morphew et al. 2007; Robinson et al. 2009; Wilson et al. 2011) . Although FhPGK is a strictly intracellular protein, the version cloned from adult fluke was previously tested as a vaccine antigen against fasciolosis (Jaros et al. 2010) . The results of the current study clearly indicate that somatic FhPGK has no role in decreased hepatocyte cell survival in vitro. Wesołowska et al. (2012) reported that adult fluke somatic proteins diminished rat hepatocyte viability in vitro even with a concentration of 20 µg/ml. This effect may have been caused due to other undefined somatic compounds and/or secretory proteins still present in secretory glands of the fluke.
